Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids.

Nelson HS, Hamilos DL, Corsello PR, Levesque NV, Buchmeier AD, Bucher BL.

Am Rev Respir Dis. 1993 Feb;147(2):398-404.

PMID:
8430965
2.

Effect of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children.

Ball BD, Hill MR, Brenner M, Sanks R, Szefler SJ.

Ann Allergy. 1990 Jul;65(1):37-45.

PMID:
2195921
4.

Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma.

Kamada AK, Hill MR, Iklé DN, Brenner AM, Szefler SJ.

J Allergy Clin Immunol. 1993 Apr;91(4):873-82.

PMID:
8473676
5.

Efficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma.

Zeiger RS, Schatz M, Sperling W, Simon RA, Stevenson DD.

J Allergy Clin Immunol. 1980 Dec;66(6):438-46.

PMID:
6968762
6.

Troleandomycin in the treatment of difficult asthma.

Siracusa A, Brugnami G, Fiordi T, Areni S, Severini C, Marabini A.

J Allergy Clin Immunol. 1993 Nov;92(5):677-82.

PMID:
8227858
7.

Dose- and time-related effect of troleandomycin on methylprednisolone elimination.

Szefler SJ, Brenner M, Jusko WJ, Spector SL, Flesher KA, Ellis EF.

Clin Pharmacol Ther. 1982 Aug;32(2):166-71.

PMID:
6980076
8.

An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma.

Wald JA, Friedman BF, Farr RS.

J Allergy Clin Immunol. 1986 Jul;78(1 Pt 1):36-43.

PMID:
3487564
9.

Steroid-specific and anticonvulsant interaction aspects of troleandomycin-steroid therapy.

Szefler SJ, Ellis EF, Brenner M, Rose JQ, Spector SL, Yurchak AM, Andrews F, Jusko WJ.

J Allergy Clin Immunol. 1982 May;69(5):455-60.

PMID:
6978898
10.

Use of TAO without methylprednisolone in the treatment of severe asthma.

Rosenberg SM, Gerhard H, Grunstein MM, Schramm CM.

Chest. 1991 Sep;100(3):849-50.

PMID:
1889284
11.
12.

The effect of troleandomycin on methylprednisolone elimination.

Szefler SJ, Rose JQ, Ellis EF, Spector SL, Green AW, Jusko WJ.

J Allergy Clin Immunol. 1980 Dec;66(6):447-51.

PMID:
6968763
13.

Fatal varicella in a corticosteroid-dependent asthmatic receiving troleandomycin.

Lantner R, Rockoff JB, DeMasi J, Boran-Ragotzy R, Middleton E Jr.

Allergy Proc. 1990 Mar-Apr;11(2):83-7.

PMID:
2338242
14.

Effect of low-dose troleandomycin on theophylline clearance: implications for therapeutic drug monitoring.

Kamada AK, Hill MR, Brenner AM, Szefler SJ.

Pharmacotherapy. 1992;12(2):98-102.

PMID:
1570234
15.

Methylprednisolone and troleandomycin in treatment of steroid-dependent asthmatic children.

Eitches RW, Rachelefsky GS, Katz RM, Mendoza GR, Siegel SC.

Am J Dis Child. 1985 Mar;139(3):264-8.

PMID:
3872062
16.
17.

[Experiences with a combination therapy of methylprednisolone and troleandomycin in severe bronchial asthma requiring high-dose corticoids].

Menz G, Rothe T, Schmitt M, Schmitz M, Hauser F, Haack D, Virchow C.

Pneumologie. 1990 Feb;44 Suppl 1:238-40. German.

PMID:
2367377
18.

Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.

Pediatrics. 2001 Aug;108(2):E36.

PMID:
11483846
19.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
20.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110

Supplemental Content

Support Center